Morgan Stanley’s Nutriband NTRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,500
Closed -$15.9K 8436
2025
Q4
$15.9K Hold
3,500
﹤0.01% 6769
2025
Q3
$24.7K Hold
3,500
﹤0.01% 6617
2025
Q2
$27.5K Sell
3,500
-49
-1% -$308 ﹤0.01% 6544
2025
Q1
$21.8K Buy
+3,549
New +$23.3K ﹤0.01% 6547
2024
Q3
Sell
-3,200
Closed -$17.3K 7999
2024
Q2
$17.3K Buy
+3,200
New +$14.7K ﹤0.01% 6515
2023
Q1
Sell
-464
Closed -$1.67K 7797
2022
Q4
$1.67K Buy
+464
New +$1.83K ﹤0.01% 7400
2022
Q1
Sell
-5,803
Closed -$50K 8063
2021
Q4
$50K Buy
+5,803
New +$29.4K ﹤0.01% 6815

Other funds holding NTRB

Morgan Stanley's NTRB Position: Q1 2026 in Review

Morgan Stanley sold out of Nutriband (NTRB) in Q1 2026, closing a stake of 3,500 shares — an estimated $15.9K sold.

Morgan Stanley first reported a position in NTRB in Q4 2021 and held it in 7 quarters. The position peaked at $50K in Q4 2021. 14 funds tracked by Wall St. Rank hold NTRB as of Q1 2026.

  • Morgan Stanley reported no remaining Nutriband position as of Q1 2026 after selling out during the quarter.
  • Morgan Stanley sold 3,500 Nutriband shares in Q1 2026, an estimated $15.9K.
  • Morgan Stanley first reported a position in Nutriband in Q4 2021 and held it in 7 quarters.
  • Morgan Stanley's Nutriband position peaked at $50K in Q4 2021.
  • 14 funds tracked by Wall St. Rank held Nutriband as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.